Skip to main content
NIH funding notice RFA-DA-25-051

Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)

Closed on March 14, 2024.

Posted
October 25, 2023
Close date
March 14, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $400,000 in first-year total cost, median $400,000.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-S (O1)]1

Most frequent institutions

  1. MOUNTAINPASS TECHNOLOGY, LLC1
Competing awards under RFA-DA-25-051 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025MyTrials: An Integrated Tool to Support Remote Biomarker Capture within Decentralized Clinical Trials for Substance Use Disorders1R42DA062250-01DAHNE, JENNIFER RENEEMOUNTAINPASS TECHNOLOGY, LLC, MD$400,000ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-25-051: Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) | ScienceDex | ConductScience